Daiichi Sankyo

Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.

Top management presentation and related reference materials for Daiichi Sankyo’s fiscal year 2012 (April 1, 2012, to March 31, 2013) business results

	Date	Description
	2013.06.19	Kitasato Daiichi Sankyo Vaccine Submits a New Drug Application in Japan for the Cell Culture-Based Pandemic Influenza Vaccine
	2013.06.18	Daiichi Sankyo Submits a New Drug Application in Japan for the Antiplatelet Agent Prasugrel
	2013.06.13	Helping Vietnam Start Domestic Production of a Measles-Rubella Combined Vaccine
	2013.06.11	Daiichi Sankyo Launches Novel Osteoporosis Treatment PRALIA® Subcutaneous Injection 60mg Syringe
	2013.05.31	Daiichi Sankyo's 8th Ordinary General Meeting of Shareholders to be held in Tokyo on Friday, June 21.